查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1935646

全螺纹缝合锚钉市场（按锚钉类型、材料、应用和最终用户划分），全球预测（2026-2032）

Fully Threaded Suture Anchor Market by Anchor Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年全螺纹缝合锚钉市场价值为 7.093 亿美元，预计到 2026 年将成长至 7.664 亿美元，年复合成长率为 8.07%，到 2032 年将达到 12.2145 亿美元。

关键市场统计数据
基准年 2025 7.093亿美元
预计年份：2026年 7.664亿美元
预测年份 2032 12.2145亿美元
复合年增长率 (%) 8.07%

这是一个清晰且有临床依据的关于全螺纹缝合锚钉的介绍，解释了为什么在医疗保健系统中，植入设计与临床工作流程的一致性至关重要。

全螺纹缝合锚钉已成为肩关节修復手术的关键技术，可提供牢固的组织固定并提高关节镜的效率。这些装置常用于关节唇和肩迴旋肌修復，其机械可靠性和易于植入的特性直接影响手术效果和术后復健。随着手术技术向微创方向发展，锚钉的设计、材料选择和植入机制在临床应用和采购决策中发挥越来越重要的作用。

变革性变化正在重塑全螺纹缝合锚钉的临床、技术和商业性格局

由于临床、技术和报销方面的协同效应，全螺纹缝合锚钉的市场格局正在发生显着变革时期。在临床方面，关节镜手术技术的不断改进以及对基于价值的治疗结果日益重视，促使外科医生和采购团队优先选择能够在退化性和创伤性组织中提供可靠固定，同时又能降低手术复杂性的锚钉。因此，设计创新正着重于缝线管理、简化的无结植入方案以及无需额外手术步骤即可适应多种骨骼类型的结构。

分析2025年美国关税对植入製造商的采购、製造、定价趋势及供应链风险的影响

美国于2025年实施的一系列关税措施，立即增加了全螺纹缝合锚钉领域製造商和医疗器材采购商的营运复杂性。这些措施影响了零件的成本结构，尤其是那些依赖国际原材料和海外製造组装的企业。进口关税提高了某些投入品的到岸成本，迫使製造商决定是否自行承担额外成本、与供应商重新谈判条款，或重新设计供应链以降低风险。

关键細項分析揭示了使用者偏好、材料权衡以及按锚点类型、材料、应用和临床环境分類的临床应用案例。

细分市场分析揭示了影响临床选择和商业化策略的产品和采购趋势的显着差异。在锚钉类型方面，无结锚钉在需要快速缝合和缩短手术时间的情况下越来越受欢迎。然而，当某些外科医生优先考虑对张力和固定的绝对控制时，有结锚钉仍然有用。这些偏好因医疗机构和外科医生群体而异，无结锚钉通常因其工作流程优势而更具吸引力，而有结锚钉则往往在复杂修復中提供更大的灵活性。

区域观点，重点分析美洲、欧洲、中东和非洲以及亚太地区的缝合锚钉采用模式、法规环境和成长驱动因素

区域趋势将显着影响全螺纹缝合锚钉的研发、监管和应用进展。在美洲，高手术量、强大的公立和私人医疗保险体係以及对循证采购的重视共同推动了临床应用。该地区的医生往往需要可靠的临床数据和简化的器械，而供应商则需要在竞争激烈的市场环境中应对，服务、培训和分销商关係在其中发挥着至关重要的作用。该地区的监管路径，尤其註重上市后监测和明确的医疗设备分类，正在影响新产品的上市速度。

深入分析全螺纹缝合锚市场主要企业的创新驱动因素、差异化策略和竞争定位

全螺纹缝合锚钉领域的竞争地位取决于产品创新、临床证据累积和市场推广执行三者之间的平衡。主要企业透过改进输送系统、材料科学和临床医生支援计划来脱颖而出。能够缩短手术时间、简化缝线管理并实现与现有器械相容的创新正获得常用用户的强力支援。投资于外科医生培训、专用手术包和真实临床数据收集的企业通常能在医疗机构的竞标中更快获得支援。

针对希望加强市场地位、降低供应链风险并加速全螺纹缝合锚钉临床应用的行业领导者的具体建议

产业领导者应优先考虑制定一套连贯的策略，将产品开发、临床证据产生和供应链韧性联繫起来。首先，将设计重点与外科医生的工作流程相匹配——例如改进缝合线管理、降低器械复杂性以及确保与常用锚钉相容——将加速临床应用并简化采购决策。透过可靠的临床研究和真实世界註册研究来补充这些产品改进，将建立引人注目的价值提案，并支持产品被纳入医疗机构的处方集。

调查方法概述了用于综合全螺纹缝合锚钉知识的资料来源、分析方法、三角测量技术和检验通讯协定。

为了确保研究途径的严谨性和相关性，我们采用了多方法架构。主要研究包括对骨科医生、采购主管和供应链经理进行深度访谈，以获取关于临床需求、器械偏好和采购行为的第一手资讯。这些定性见解辅以监管指南、临床文献和手术操作规范的二手研究，从而建立器械应用案例和材料选择的客观标准。

总之，我们总结了临床医生、製造商和医疗保健负责人在应对全螺纹缝合锚钉环境时所面临的战略意义。

全螺纹缝合锚钉领域正处于转折点，其特点是材料创新、技术改进以及对产品价值日益严格的商业性考虑。临床医生越来越需要能够无缝整合到关节镜流程中，并在各种组织类型中提供可靠机械性能的锚钉。那些透过迭代设计改进、循证推广和以外科医生为中心的培训计画来满足需求的製造商，将更有利于在门诊和住院环境中获得广泛应用。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 全螺纹缝合锚钉市场（按锚钉类型划分）

  • 没有绳结
  • 存在结节

9. 全螺纹缝合锚钉市场（依材料划分）

  • 可生物降解聚合物
  • PEEK（聚醚醚酮）
  • 不銹钢
  • 钛

第十章 全螺纹缝合锚钉市场依应用领域划分

  • 关节唇修復
  • 肩迴旋肌修復

第十一章 全螺纹缝合锚钉市场（依最终用户划分）

  • 门诊手术中心
  • 医院
    • 大学医院
    • 社区医院
  • 专科诊所

第十二章 全螺纹缝合锚钉市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 全螺纹缝合锚钉市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国全螺纹缝合锚钉市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国全螺纹缝合锚钉市场

第十六章 中国全螺纹缝合锚钉市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acumed, LLC
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun AG
  • Bioventus
  • CONMED Corporation
  • Enovis Corporation
  • Johnson & Johnson Services, Inc.
  • Keyi Bangen
  • LimaCorporate
  • Medos International
  • Medtronic plc
  • MJ Surgical
  • Orthofix Medical Inc.
  • Ossio, Inc.
  • Parcus Medical LLC
  • Rejoin Medical Device Co., Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Tokyo Ohka Kogyo Co., Ltd.
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-9A6A6F29744C

The Fully Threaded Suture Anchor Market was valued at USD 709.30 million in 2025 and is projected to grow to USD 766.40 million in 2026, with a CAGR of 8.07%, reaching USD 1,221.45 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 709.30 million
Estimated Year [2026] USD 766.40 million
Forecast Year [2032] USD 1,221.45 million
CAGR (%) 8.07%

A clear, clinically grounded introduction to fully threaded suture anchors explaining why implant design and clinical workflow alignment matter for healthcare systems

Fully threaded suture anchors have emerged as a critical technology in shoulder repair procedures, offering secure tissue fixation and streamlined arthroscopic workflows. The devices are frequently used in labral and rotator cuff repairs, where mechanical reliability and ease of deployment directly influence surgical outcomes and postoperative rehabilitation pathways. As surgical techniques evolve toward minimally invasive approaches, anchor design, material selection, and deployment mechanisms play increasingly prominent roles in shaping clinical adoption and procurement choices.

Clinicians seek implants that reduce operative time, lower the risk of anchor-related complications, and deliver reproducible fixation strength across diverse tissue qualities. Concurrently, hospital systems and ambulatory surgical centers prioritize devices that support predictable throughput, cost containment, and durable clinical outcomes that minimize readmissions and revision procedures. These dual imperatives-clinical performance and system-level efficiency-define the competitive landscape for fully threaded suture anchors.

Innovation in materials and construct design has broadened the set of trade-offs available to device developers, enabling combinations that balance resorbability, radiolucency, and long-term mechanical integrity. The interplay among anchor geometry, suture management strategies, and delivery instrumentation continues to influence user preference and procurement frameworks. Looking ahead, alignment between product development and the operational needs of end users will determine which solutions translate into sustained adoption across care settings.

Transformative shifts reshaping the clinical, technological, and commercial landscape for fully threaded suture anchors

The landscape for fully threaded suture anchors is undergoing a period of meaningful transformation driven by converging clinical, technological, and reimbursement dynamics. On the clinical front, the steady refinement of arthroscopic techniques and growing emphasis on value-based outcomes have pushed surgeons and procurement teams to favor anchors that reduce procedure complexity while delivering reliable fixation in both degenerative and traumatic tissue contexts. As a result, design innovation has prioritized suture management, streamlined knotless deployment options, and constructs that accommodate variable bone quality without adding surgical steps.

Technological momentum centers on material science and device integration. Advances in polymer formulation and bioresorbable composites are enabling implants that maintain early mechanical security and then gradually transfer load to healing tissues, potentially reducing imaging artifacts and facilitating follow-up evaluations. Simultaneously, high-performance non-resorbable options such as PEEK and titanium remain essential where long-term mechanical durability and radiographic clarity are prioritized. The desire to reconcile these competing requirements has spurred iterative improvements in anchor geometry and thread profiles that enhance pullout resistance while minimizing bone disruption.

Commercially, procurement strategies are shifting as providers place greater emphasis on total episode value rather than unit price alone. Value-based purchasing and bundled payment paradigms encourage closer collaboration among device manufacturers, surgical teams, and supply chain managers to demonstrate reproducible outcomes, predictable inventories, and instrumentation compatibility. This has amplified the importance of evidence generation-clinical registries, head-to-head comparative studies, and real-world outcomes data-to substantiate claims of improved efficiency or reduced complications. Taken together, these shifts are catalyzing a market environment in which clinical differentiation, supply chain responsiveness, and evidence-backed value propositions determine long-term success.

Analysis of how United States tariffs implemented in 2025 influenced sourcing, manufacturing, pricing dynamics, and supply chain risk for implant manufacturers

The set of tariff measures introduced in the United States in 2025 introduced an immediate layer of complexity for manufacturers and healthcare purchasers operating in the fully threaded suture anchor space. These measures affected the cost structure of components, particularly for companies that relied on internationally sourced raw materials or overseas manufacturing and assembly. As import duties raised landed costs for certain inputs, manufacturers faced decisions about whether to absorb additional expenses, renegotiate supplier terms, or redesign supply chains to mitigate exposure.

In response, several strategic adjustments became more common. Some device makers accelerated nearshoring efforts or consolidated suppliers to secure more predictable pricing and lead times. Others initiated product redesigns to substitute materials with locally available alternatives where clinically acceptable, or to simplify the bill of materials and reduce the number of imported subcomponents. These tactical shifts aimed to preserve competitive pricing while maintaining clinical performance, yet they required targeted investments in validation and regulatory documentation to ensure continued product compliance and safety.

The tariffs also influenced commercial discussions between manufacturers and healthcare providers. Contract negotiations increasingly incorporated clauses addressing tariff pass-through, inventory hedging strategies, and longer-term supply commitments to offset volatility. Procurement teams adjusted tendering timelines and inventory strategies, balancing the risk of short-term cost increases against the operational imperative to avoid procedural disruptions. For some manufacturers, the cumulative effect prompted reassessment of global manufacturing footprints, prioritizing locations with favorable trade treatments and stable logistics.

Ultimately, the tariffs underscored the importance of supply chain resilience and strategic sourcing in a constrained trade environment. Firms that proactively diversified supplier bases, invested in local validation capabilities, and transparently communicated tariff-related impacts to customers were better positioned to protect margins and sustain market access, while others faced elevated cost pressures that constrained commercial flexibility.

Key segmentation insights that illuminate user preferences, material trade-offs, and clinical use cases across anchor types, materials, applications, and care settings

Segmentation analysis reveals distinct product and procurement dynamics that shape clinical choice and commercialization strategies. When anchors are compared by anchor type, knotless designs are increasingly favored in contexts where rapid suture management and shorter operative times are valued, and knotted anchors retain relevance where absolute control of tension and fixation is prioritized by certain surgeons. These preferences manifest differently across institutions and surgeon cohorts, with knotless solutions often marketed for their workflow advantages and knotted options emphasized for perceived versatility in complex repairs.

Material segmentation exposes the nuanced trade-offs among biodegradable polymers, PEEK, stainless steel, and titanium. Biodegradable polymers appeal to clinicians concerned about long-term implant remnants and imaging interference, though they require careful consideration of early mechanical retention and predictable resorption profiles. PEEK delivers radiolucency and favorable biomechanical characteristics, while stainless steel and titanium preserve long-term mechanical integrity and are frequently selected in cases where permanent support is clinically indicated. The selection process hinges on the interplay of clinical indication, imaging needs, and surgeon comfort with material handling.

Application-based segmentation highlights differences between labral repair and rotator cuff repair usage patterns. Labral repairs often prioritize anchors that facilitate precise suture placement in constrained spaces and that accommodate soft-tissue reattachment with minimal bone removal. Rotator cuff repairs, in contrast, demand constructs that balance pullout resistance with tendon-to-bone compression mechanics, as well as implantation systems that support robust footprint restoration. These divergent application demands inform product design choices and procedural training priorities.

End user segmentation-spanning ambulatory surgical centers, hospitals, and specialty clinics-reveals how care setting influences procurement and product adoption. Ambulatory surgical centers typically emphasize devices that enable rapid turnover and predictable inventory usage. Hospitals, further distinguished into academic and community settings, bring varying priorities: academic hospitals often focus on device flexibility that supports research and complex cases, while community hospitals weigh cost-effectiveness and standardization to manage volumes and budgets. Specialty clinics concentrate on procedural efficiency and surgeon familiarity, influencing the selection of anchor constructs and instrumentation that align with practice patterns.

Regional perspectives that highlight adoption patterns, regulatory contexts, and growth enablers across the Americas, EMEA, and Asia-Pacific markets for suture anchors

Regional dynamics materially influence how fully threaded suture anchors are developed, regulated, and adopted. In the Americas, clinical adoption tends to be driven by a combination of high procedural volumes, robust private and public payer mechanisms, and an emphasis on evidence-based procurement. Surgeons in the region often demand strong clinical data and streamlined instrumentation, and suppliers navigate a competitive environment where service, training, and distributor relationships play decisive roles. Regulatory pathways in the region emphasize post-market surveillance and clear device classifications, shaping the cadence of new product introductions.

Europe, the Middle East & Africa presents a heterogeneous landscape where regulatory harmonization initiatives coexist with country-level procurement idiosyncrasies. Reimbursement frameworks vary widely, prompting manufacturers to craft tailored value propositions that account for differential macroeconomic conditions and hospital purchasing cycles. Clinical practice patterns also reflect regional training emphases and public versus private care mixes, which in turn affect the relative appeal of certain anchor types and materials. Market entry strategies must therefore balance centralized regulatory approaches with local commercial partnerships.

Asia-Pacific is characterized by rapid adoption in selected markets, an increasing focus on orthopaedic procedural capacity building, and diverse regulatory environments that range from highly structured approval regimes to more emergent frameworks. Demand drivers in the region include rising access to specialized surgical care, growing investments in ambulatory surgical infrastructure, and an emphasis on cost-conscious innovation. Manufacturers targeting this region often tailor product breadth and pricing strategies to accommodate varied payer landscapes and surgeon training needs. Across all regions, cross-border collaborations, local clinical evidence generation, and targeted training programs remain essential to secure sustained uptake.

Insights on key companies driving innovation, differentiation strategies, and competitive positioning within the fully threaded suture anchor ecosystem

Competitive positioning in the fully threaded suture anchor space balances product innovation, clinical evidence generation, and go-to-market execution. Leading companies are differentiating through improvements in delivery systems, material science, and clinician support programs. Innovations that reduce procedure time, simplify suture management, and offer compatibility with established instrumentation pathways tend to resonate strongly with high-volume users. Firms that invest in surgeon training, procedure-specific kits, and real-world evidence collection typically gain more rapid traction in institutional tenders.

Strategic partnerships and targeted acquisitions are common tactics to broaden portfolios and accelerate access to complementary technologies such as suture management systems, biologic augmentation, and advanced imaging-compatible materials. Companies that can demonstrate reproducible outcomes through peer-reviewed studies, registry data, and surgeon-led publications often find it easier to secure formulary inclusion and to justify premium positioning where warranted by clinical performance.

Operational excellence in manufacturing and supply chain reliability also serves as a competitive differentiator. Firms that maintain tight quality systems, streamlined logistics, and transparent inventory practices reduce operational risk for healthcare providers and foster long-term procurement relationships. Finally, pricing strategy remains a lever-some companies pursue volume-based models with standardized kits to compete on total episode value, while others focus on differentiated features and premium services to defend higher price points. The ability to align product, evidence, and commercial execution defines leadership in this sector.

Actionable recommendations for industry leaders seeking to strengthen market position, de-risk supply chains, and accelerate clinical adoption of fully threaded suture anchors

Industry leaders should prioritize a coherent strategy that links product development, clinical evidence generation, and supply chain resilience. First, aligning design priorities with surgeon workflow-such as improving suture management, reducing instrumentation complexity, and ensuring compatibility with commonly used anchors-will accelerate clinical adoption and ease procurement decisions. Complementing these product improvements with robust clinical studies and real-world registries will create a defensible value narrative and support inclusion in institutional formularies.

Second, supply chain diversification is essential to withstand trade policy fluctuations and component scarcity. Establishing multi-source procurement strategies, nearshoring critical manufacturing steps where feasible, and maintaining validated secondary suppliers can materially reduce exposure to tariff- and logistics-related disruptions. Transparent communication with customers about sourcing strategies and inventory practices builds trust and supports longer-term contracting arrangements.

Third, manufacturers should invest in tailored commercial models that reflect end user needs across ambulatory surgical centers, hospitals, and specialty clinics. Offering flexible contracting options, training bundles, and clinical support services helps drive adoption in both high-throughput ambulatory settings and complex academic centers. Finally, targeted regional strategies that incorporate local regulatory expertise, evidence generation partnerships, and distributor selection will enable more efficient market entry and sustained growth across diverse geographies.

Research methodology outlining data sources, analytical approaches, triangulation techniques, and validation protocols employed in synthesizing the fully threaded suture anchor intelligence

The research approach combined a multi-method framework to ensure rigor and relevance. Primary research included in-depth interviews with orthopaedic surgeons, procurement leaders, and supply chain managers to capture first-hand perspectives on clinical needs, device preferences, and purchasing behaviors. These qualitative inputs were complemented by secondary research into regulatory guidance, clinical literature, and procedural practice standards to establish an objective baseline of device use cases and material considerations.

Analytical methods emphasized triangulation and cross-validation. Insights from clinical interviews were tested against published peer-reviewed studies and regulatory documentation to confirm safety and performance themes. Supply chain analysis drew upon industry logistics reports and trade policy summaries to assess risk exposure, while competitive intelligence was built from company disclosures, product literature, and conference presentations to map differentiation strategies and capability gaps.

Validation protocols included expert review panels consisting of practising surgeons and hospital procurement specialists who reviewed preliminary findings and provided feedback on clinical relevance and commercial practicability. Where appropriate, technical claims and material performance assertions were cross-checked against biomechanical studies and device instructions for use to ensure factual accuracy. This layered methodology supports robust conclusions while acknowledging the evolving nature of clinical practice and regulatory environments.

Conclusion synthesizing strategic implications for clinicians, manufacturers, and healthcare buyers navigating the fully threaded suture anchor environment

The fully threaded suture anchor domain is at an inflection point characterized by material innovation, procedural refinement, and heightened commercial scrutiny around value. Clinicians increasingly demand anchors that integrate seamlessly into arthroscopic workflows while delivering dependable mechanical performance across a range of tissue qualities. Manufacturers that respond with thoughtful design iteration, evidence-driven claims, and surgeon-centric training programs will be better positioned to secure adoption in both ambulatory and hospital environments.

Supply chain resilience and adaptable sourcing strategies have become central to commercial viability, particularly in the face of trade policy variability and component market fluctuations. Transparent engagement with customers about sourcing, inventory management, and price stability builds trust and reduces negotiation friction. Moreover, regional strategies that reflect regulatory nuances and local clinical practices will be critical to scaling successfully across distinct geographies.

In aggregate, market participants that unite clear clinical differentiation, operational reliability, and credible evidence generation can convert technological advantages into sustainable commercial outcomes. The path forward rewards integrated approaches that align product capabilities with the workflows and priorities of surgeons, procurement teams, and institutional stakeholders.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fully Threaded Suture Anchor Market, by Anchor Type

  • 8.1. Knotless
  • 8.2. Knotted

9. Fully Threaded Suture Anchor Market, by Material

  • 9.1. Biodegradable Polymers
  • 9.2. PEEK (Polyether Ether Ketone)
  • 9.3. Stainless Steel
  • 9.4. Titanium

10. Fully Threaded Suture Anchor Market, by Application

  • 10.1. Labral Repair
  • 10.2. Rotator Cuff Repair

11. Fully Threaded Suture Anchor Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Academic Hospitals
    • 11.2.2. Community Hospitals
  • 11.3. Specialty Clinics

12. Fully Threaded Suture Anchor Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fully Threaded Suture Anchor Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fully Threaded Suture Anchor Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fully Threaded Suture Anchor Market

16. China Fully Threaded Suture Anchor Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acumed, LLC
  • 17.6. Anika Therapeutics, Inc.
  • 17.7. Arthrex, Inc.
  • 17.8. B. Braun AG
  • 17.9. Bioventus
  • 17.10. CONMED Corporation
  • 17.11. Enovis Corporation
  • 17.12. Johnson & Johnson Services, Inc.
  • 17.13. Keyi Bangen
  • 17.14. LimaCorporate
  • 17.15. Medos International
  • 17.16. Medtronic plc
  • 17.17. MJ Surgical
  • 17.18. Orthofix Medical Inc.
  • 17.19. Ossio, Inc.
  • 17.20. Parcus Medical LLC
  • 17.21. Rejoin Medical Device Co., Ltd.
  • 17.22. RTI Surgical, Inc.
  • 17.23. Smith & Nephew plc
  • 17.24. Stryker Corporation
  • 17.25. Tokyo Ohka Kogyo Co., Ltd.
  • 17.26. Wright Medical Group N.V.
  • 17.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY KNOTTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY PEEK (POLYETHER ETHER KETONE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY LABRAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ROTATOR CUFF REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ACADEMIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GCC FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. G7 FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NATO FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY ANCHOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA FULLY THREADED SUTURE ANCHOR MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)